Initial capsid-specific CD4+ T cell responses protect against Theiler's murine encephalomyelitis virus-induced demyelinating disease

European Journal of Immunology

Volumn 36, Issue 8, 2006, Pages 2106-2115

  Mohindru, Mani ^a,b   Kang, Bongsu ^a   Kim, Byung S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UBS Investment Bank   (United States)

Author keywords

Apoptosis; CD4+; CNS; Demyelination; T cells; TMEV

Indexed keywords

CAPSID PROTEIN; CD3 ANTIBODY; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; FEMALE; FLOW CYTOMETRY; IMMUNIZATION; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; MOUSE; MOUSE STRAIN; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; VIRUS CAPSID; VIRUS INFECTION;

ACUTE DISEASE; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CAPSID PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DEMYELINATING DISEASES; DISEASE TRANSMISSION; FEMALE; IMMUNIZATION; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; THEILOVIRUS; TIME FACTORS;

EID: 33747434851     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535785     Document Type: Article

References (45)

1. Cermelli, C. and Jacobson, S., Viruses and multiple sclerosis. Viral Immunol. 2000.13: 255-267.
2. Theiler, M., Spontaneous encephalomyelitis of mice: a new virus disease. J. Exp. Med. 1937. 65: 705-719.
3. Lipton, H. L., Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect. Immun. 1975. 11: 1147-1155.
4. Lipton, H. L. and Dal Canto, M. C., Theiler's virus-induced demyelination: prevention by immunosuppression. Science 1976. 192: 62-64.
5. Friedmann, A., Frankel, G., Lorch, Y. and Steinman, L., Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: critical importance of timing of treatment. J. Virol. 1987. 61: 898-903.
6. Rodriguez, M., Lafuse, W. P., Leibowitz, J. and David, C. S., Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (la antigens). Neurology 1986. 36: 964-970.
7. Kim, B. S., Palma, J. P., Inoue, A. and Koh, C. S., Pathogenic immunity in Theiler's virus-induced demyelinating disease: a viral model for multiple sclerosis. Arch. Immunol. Ther. Exp. 2000. 48: 373-379.
8. Lipton, H. L., Kratochvil, J., Sethi, P. and Dal Canto, M. C., Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection. Neurology 1984. 34: 1117-1119.
9. Rodriguez, M., Leibowitz, J. and Lampert, P., Persistent infection of oligodendrocytes in Theiler's virus induced encephalomyelitis. Ann. Neurol. 1983. 13: 426-433.
10. Fiette, L., Aubert, C., Brahic, M. and Rossi, C. P., Theiler's virus infection of beta 2-microglobulin-deficient mice. J. Virol. 1993. 67: 589-592.
11. Pullen, L. C., Miller, S. D., Dal Canto, M. C. and Kim, B. S., Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 1993. 23: 2287-2293.
12. Rodriguez, M., Dunkel, A. J., Thiemann, R. L., Leibowitz, J., Zijlstra, M. and Jaenisch, R., Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin. J. Immunol. 1993. 151: 266-276.
13. Murray, P. D., McGavern, D. B., Lin, X., Njenga, M. K., Leibowitz, J., Pease, L. R. and Rodriguez, M., Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J. Neurosci. 1998. 18: 7306-7314.
14. Palma, J. P. and Kim, B. S., Induction of selected chernokines in glial cells infected with Theiler's virus. J. Neuroimmunol. 2001. 117: 166-170.
15. + T cells in the central nervous system of susceptible SJL /J mice infected with Theiler's virus are virus specific and fully functional. J. Virol. 2002. 76: 6577-6585.
16. b-restricted regions of the BeAn strain of Theiler's virus and exhibit different cytokine profiles. J. Virol. 2002. 76: 3125-3134.
17. + T cell responses to Theiler's murine encephalomyelitis virus between resistant C57BL/6 and susceptible SJL/J mice. Eur. J. Immunol. 2004. 34: 2730-2739.
18. + T cell line specific for an immunodominant VP2 epitope. J. Immunol. 1994. 152: 919-929.
19. Yauch, R. L. and Kim, B. S., A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VP1(233-244). J. Immunol. 1994. 153: 4508-4519.
20. Yauch, R. L., Palma, J. P., Yahikozawa, H., Koh, C. S. and Kim, B. S., Role of individual T-cell epitopes of Theiler's virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response. J. Virol. 1998. 72: 6169-6174.
21. + T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J. Virol. 1998. 72: 7320-7329.
22. Njenga, M. K., Pavelko, K. D., Baisch, J., Lin, X., David, C., Leibowitz, J. and Rodriguez, M., Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J. Virol. 1996. 70: 1729-1737.
23. 121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J. Virol. 1999. 73: 3702-3708.
24. + T-cell subset. Mult. Scler. 2002. 8: 469-474.
25. + T cells from virus-infected C57BL/6 mice. Virus Res. 2005. 108: 57-61.
26. Rodriguez, M., Pavelko, K. and Coffman, R. L., Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J. Virol. 1995. 69: 7286-7290.
27. Fiette, L., Aubert, C., Muller, U., Huang, S., Aguet, M., Brahic, M. and Bureau, J. F., Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J. Exp. Med. 1995. 181: 2069-2076.
28. Pullen, L. C., Miller, S. D., Dal Canto, M. C., Van der Meide, P. H. and Kim, B. S., Alteration in the level of interferon-gamma results in acceleration of Theiler's virus-induced demyelinating disease. J. Neuroimmunol. 1994. 55: 143-152.
29. Panitch, H. S., Hirsch, R. L., Haley, A. S. and Johnson, K. P., Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987. 1: 893-895.
30. Olsson, T., Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 1995. 144: 245-268.
31. Vartanian, T., Li, Y., Zhao, M. and Stefansson, K., Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1995. 1: 732-743.
32. Katz-Levy, Y., Neville, K. L., Girvin, A. M., Vanderlugt, C. L., Pope, J. G., Tan, L. J. and Miller, S. D., Endogenous presentation of self myelin epitopes by CNS-resident APC in Theiler's virus-infected mice. J. Clin. Invest. 1999. 104: 599-610.
33. McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H. and Miller, S. D., Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005. 11: 335-339.
34. Miller, S. D., Vanderlugt, C. L., Begolka, W. S., Pao, W., Yauch, R. L., Neville, K. L., Katz-Levy, Y. et al., Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 1997 3: 1133-1136.
35. Kang, J. A., Mohindru, M., Kang, B. S., Park, S. H. and Kim, B. S., Clonal expansion of infiltrating T cells in the spinal cords of SJL/J mice infected with Theiler's virus. J. Immunol. 2000. 165: 583-590.
36. + Tregs: limiting collateral damage. J. Clin. Invest. 2004. 114: 1372-1378.
37. Noben-Trauth, N., Kropf, P. and Muller, I., Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 1996. 271: 987-990.
38. Powrie, F., Menon, S. and Coffman, R. L., Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo [published erratum appears in Eur. J. Immunol. 1994 Mar; 24(3):785]. Eur. J. Immunol. 1993. 23: 2223-2229.
39. Abbas, A. K., Murphy, K. M. and Sher, A., Functional diversity of helper T lymphocytes. Nature 1996. 383: 787-793.
40. Kim, B. S., Palma, J. P., Kwon, D. and Fuller, A. C., Innate immune response induced by Theiler's marine encephalomyelitis virus infection. Immunol. Res. 2005. 31: 1-12.
41. Jellison, E. R., Kim, S. K. and Welsh, R. M., Cutting edge: MHC class II-restricted killing in vivo during viral infection. J. Immunol. 2005. 174: 614-618.
42. Yauch, R. L., Kerekes, K., Saujani, K. and Kim, B. S., Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in demyelination-susceptible SJL/J mice. J. Virol. 1995. 69: 7315-7318.
43. Damle, N. K., Klussman, K., Linsley, P. S., Aruffo, A. and Ledbetter, J. A., Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7. J. Immunol. 1992. 149: 2541-2548.
44. Jung, T., Schauer, U., Heusser, C., Neumann, C. and Rieger, C., Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 1993. 159: 197-207.
45. Pullen, L. C., Park, S. H., Miller, S. D., Dal Canto, M. C. and Kim, B. S., Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. J. Immunol. 1995. 155: 4497-4503.